| [1] |
赵春梅，孙小丽，罗喜平．阻抗控制子宫内膜切除术治疗子宫异常出血的临床应用与进展[J]．中华妇幼临床医学杂志：电子版，2013，9(1)：117–119.
|
| [2] |
张以文．FIGO关于月经异常相关术语的共识和异常子宫出血病因的新分类系统[J]．国际妇产科学杂志，2013，40(2)：105–107.
|
| [3] |
Munro MG，Critchley HO，Fraser IS，et al.The FIGO classification of causes of abnormal uterine bleeding in the reproductive years[J]．Fertil Steril，2011，95 (7)：2204–2208.
|
| [4] |
Gallinat A. An impedance-controlled system for endometrial ablation: five-year follow-up of 107 patients[J]．J Reprod Med，2007，52(6)：467–472.
|
| [5] |
Kleijn JH，Engels R，Bourdrez P，et al.Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation[J]. BJOG，2008，115(2)：193–198.
|
| [6] |
Kalkat RK，Cartmill RS. NovaSure endometrial ablation under local anaesthesia in an outpatient setting：an observational study[J]．J Obstet Gynaecol, 2011，31(2)：152–155.
|
| [7] |
Asgari Z，Moini A，Samiee H，et al. Endometrial ablation with the NovaSure system in Iran[J]．Int J Gynaecol Obstet，2011，114(1)：73–75.
|
| [8] |
Baskett TF，Clough H，Scott TA.NovaSure bipolar radiofrequency endometrial ablation：report of 200 cases[J]．J Obstet Gynaecol Can，2005，27(5)：473–476.
|
| [9] |
Cooper J，Gimpelson RJ.Summary of safety and effectiveness data from FDA：a valuable source of information on the performance of global endometrial ablation devices[J]．J Reprod Med，2004，49(4)：267–273.
|
| [10] |
Sabbah R，Desaulniers G．Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease：12-month follow-up results of a prospective，single-arm clinical study[J]．J Minim Invasive Gynecol，2006，13(5)：467–471.
|
| [11] |
王子静，杨永秀．诺舒阻抗控制系统子宫内膜去除术的临床应用及进展[J]．国际生殖健康/计划生育杂志，2014，33(2)：124–127.
|
| [12] |
El-Nashar SA，Hopkins MR，Barnes SA, et al. Health-related quality of life and patient satisfaction after global endometrial ablation for menorrhagia in women with bleeding disorders：a follow-up survey and systematic review[J]．Am J Obstet Gynecol，2010，202(4)：348.e1–e7.
|
| [13] |
孙小丽，曾俐琴，张华明，等．诺舒阻抗控制系统治疗月经过多的临床研究[J]．中华妇产科杂志，2013，48(1)：55–57.
|
| [14] |
Khan Z，EI-Nashar SA，Hopkins MR，et al.Efficacy and safety of global endometrial ablation after cesarean delivery：a cohort study[J]．Am J Obstet Gynecol, 2011，205(5)：450.el–e4.
|
| [15] |
Shavell VI，Diamond MP，Senter JP，et al. Hysterectomy subsequent to endometrial ablation[J]．J Minim Invasive Gynecol，2012，19(4)：459–464.
|
| [16] |
Penninx JP，Mol BW，Engels R，et al. Bipolar radiofrequency endometrial ablation compared with hydrothermablation for dysfunctional uterine bleeding：a randomized controlled trial[J]．Obstet Gynecol，2010，116(4)：819–826.
|
| [17] |
Gimpelson RJ.Ten-year literature review of global endometrial ablation with the NovaSure device[J]．Int J Womens Health，2014，6：269–280.
|
| [18] |
Clark TJ，Samuels N，Malick S，et al.Bipolar radiofrequency compared with thermal balloon endometrial ablation in the office：a randomized controlled trial[J]. Obstet Gynecol，2011，117(5)：1228.
|
| [19] |
Daniels JP，Middleton LJ，Champaneria R，et al.Second generation endometrial ablation techniques for heavy menstrual bleeding：network meta-analysis[J]. BMJ，2012，344：e2564.
|
| [20] |
Lukes AS，McBride RJ，Herring AH，et al.Improved premenstrual syndrome symptoms after NovaSure endometrial ablation[J]．J Minim Invasive Gynecol，2011，18(5)：607–611.
|
| [21] |
ACOG Committee on Practice Bulletins-Gynecology.ACOG Practice Bulletin No.81: endometrial ablation[J]．Obstet Gynecol，2007，109(5)：1233–1248.
|
| [22] |
Smith SE，Bacher-Lind L．Pregnancy outcomes following a NovaSure○R endometrial ablation procedure[J]．J Minim Invasive Gynecol，2012，19(6)：S21.
|